102
Participants
Start Date
September 30, 2008
Primary Completion Date
July 31, 2009
Study Completion Date
September 30, 2009
Dienogest (81150037)
daily oral intake of 0.5 mg dienogest over two cycles or a max. of 72 days
Dienogest (81150231)
daily oral intake of 1.0 mg dienogest over two cycles or a max. of 72 days
Dienogest (SH T00660A)
daily oral intake of 2.0 mg dienogest over two cycles or a max. of 72 days
Dienogest (81150746)
daily oral intake of 3.0 mg dienogest over two cycles or a max. of 72 days
Groningen
Lead Sponsor
Bayer
INDUSTRY